tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Amgen price target lowered to $329 from $333 at Morgan Stanley
PremiumThe FlyAmgen price target lowered to $329 from $333 at Morgan Stanley
4d ago
Amgen’s Strong Financial Performance and Growth Potential Drive Buy Rating
Premium
Ratings
Amgen’s Strong Financial Performance and Growth Potential Drive Buy Rating
4d ago
Amgen price target raised to $300 from $280 at Wells Fargo
Premium
The Fly
Amgen price target raised to $300 from $280 at Wells Fargo
5d ago
Amgen reports Q3 adjusted EPS $5.64, consensus $5.01
PremiumThe FlyAmgen reports Q3 adjusted EPS $5.64, consensus $5.01
5d ago
Amgen raises FY25 adjusted EPS view to $20.60-$21.40 from $20.20-$21.30
Premium
The Fly
Amgen raises FY25 adjusted EPS view to $20.60-$21.40 from $20.20-$21.30
5d ago
Notable companies reporting after market close
Premium
The Fly
Notable companies reporting after market close
5d ago
Amgen, AstraZeneca announce FDA approval of Tezspire
PremiumThe FlyAmgen, AstraZeneca announce FDA approval of Tezspire
23d ago
Amgen treatment of systemic sclerosis granted FDA orphan designation
Premium
The Fly
Amgen treatment of systemic sclerosis granted FDA orphan designation
24d ago
Trump Weekly: Generics to be excluded from pharma tariff plan
Premium
The Fly
Trump Weekly: Generics to be excluded from pharma tariff plan
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100